Preclinical biodistribution and safety evaluation of a pbi-shRNA STMN1 lipoplex after subcutaneous delivery

Z Wang, CM Jay, C Evans, P Kumar… - Toxicological …, 2017 - academic.oup.com
Stathmin-1 (STMN1) is a microtubule-destabilizing protein which is overexpressed in
cancer. Its overexpression is associated with poor prognosis and also serves as a predictive …

[HTML][HTML] Phase 1 trial of Bi-shRNA STMN1 BIV in refractory cancer

M Barve, Z Wang, P Kumar, CM Jay, X Luo, C Bedell… - Molecular Therapy, 2015 - cell.com
Stathmin1 (STMN1) is a microtubule modulator that is expressed in multiple cancers and
correlates with poor survival. We previously demonstrated in vivo safety of bifunctional (bi) …

In vivo Safety and Antitumor Efficacy of Bifunctional Small Hairpin RNAs Specific for the Human Stathmin 1 Oncoprotein

AP Phadke, CM Jay, Z Wang, S Chen, S Liu… - DNA and cell …, 2011 - liebertpub.com
Bifunctional small hairpin RNAs (bi-shRNAs) are functional miRNA/siRNA composites that
are optimized for posttranscriptional gene silencing through concurrent mRNA cleavage …

RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo

D Long, T Yu, X Chen, Y Liao, X Lin - Cell Biology and Toxicology, 2018 - Springer
Stathmin (STMN) plays a vital role in maintaining the malignant behavior of cancer through
directly regulating microtubule dynamics equilibrium. Taxol, an effective chemotherapeutics …

Effectiveness of local injection of lentivirus‐delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse

J Akhtar, Z Wang, C Yu… - … of Gastroenterology and …, 2014 - Wiley Online Library
Abstract Background and Aim We have reported previously that RNA interference targeting
stathmin1 (STMN1) gene in human gastric cancer cells inhibits proliferation in vitro and …

Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference

DD Rao, PB Maples, N Senzer, P Kumar, Z Wang… - Cancer gene …, 2010 - nature.com
RNA interference (RNAi) is a natural cellular regulatory process that inhibits gene
expression by transcriptional, post-transcriptional and translational mechanisms. Synthetic …

[HTML][HTML] Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo

J Akhtar, Z Wang, ZP Zhang, MM Bi - Journal of translational medicine, 2013 - Springer
Background Gastric cancer is highly aggressive disease. Despite advances in diagnosis
and therapy, the prognosis is still poor. Various genetic and molecular alterations are found …

RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model

FL Byrne, L Yang, PA Phillips, LM Hansford, JI Fletcher… - Oncogene, 2014 - nature.com
Metastatic neuroblastoma is an aggressive childhood cancer of neural crest origin. Stathmin,
a microtubule destabilizing protein, is highly expressed in neuroblastoma although its …

High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics

J Shen, R Xu, J Mai, HC Kim, X Guo, G Qin, Y Yang… - ACS …, 2013 - ACS Publications
Gene silencing agents such as small interfering RNA (siRNA) and microRNA offer the
promise to modulate expression of almost every gene for the treatment of human diseases …

Effects on the STAT3-shRNA in non-small-cell lung cancer therapy: design, induction of apoptosis, and conjugation with chitosan-based gene vectors

W Zhang, Y Zhang, Z Jiang, L Sun, L Wang… - Journal of Ocean …, 2021 - Springer
STAT3 plays a particularly important role in several cancer-related signal transduction
pathways. Silencing STAT3 via RNA interference or small molecule inhibitors induces the …